456. How to Fix the Hot Mess of U.S. Hea...

<p>A Trump executive order is giving retail investors more access to private markets. Is that a golden opportunity — or fool’s gold?</p><p> </p><ul><li><strong>SOURCES:</strong><ul><li><a href="https://law.duke.edu/fac/defontenay/">Elisabeth de Fontenay,</a> professor of law at D ... Show More

<p>Thoroughbred auction prices keep setting records. But tracks are closing, gambling revenues are falling, and the sport is increasingly reliant on subsidies. Is that the kind of long shot anybody wants? (Part three of a series, “<a href="https://freakonomics.com/the-horse-is-us ... Show More

<p>The world has changed a good bit since <i>Freakonomics</i> was first published. In this live anniversary episode, Stephen Dubner tells Geoff Bennett of <i>PBS NewsHour </i>everything he has learned since then. Happy birthday, <i>Freakonomics.</i></p><p> </p><ul><li><strong>SOU ... Show More

Much of medicine doesn’t do what it is supposed to do: improve health. That is the view of orthopaedic surgeon, Ian Harris. Ian believes too many drugs are being prescribed, too much surgery is being performed, and there are too many unhelpful tests, scans, and overdiagnosis. The ... Show More

<p>Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to ... Show More

<p>Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to ... Show More

<p>Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to ... Show More

<p>Modern American health care is defined by its high costs, high overhead and inaccessibility -- especially for low-income patients. What if we could redesign the system to serve the poor and still have doctors make money? In an eye-opening (and surprisingly funny) talk, physici ... Show More

Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ... Show More

America’s medical system, along with most doctors, was not prepared to think outside the box to treat COVID, according to today’s guest. Dr. Mobeen Syed is founder of DrBeen, a medical education program designed to train today’s doctors in medical innovation. He is one of the doc ... Show More

After the Supreme Court’s abortion decision, doctors in some states are concerned that delivering treatment could put them in legal jeopardy. Bapu Jena looks at how the practice of “defensive medicine” can compromise patient care.  

<p>with Vas Narasimhan (@vasnarasimhan), Jorge Conde (@jorgecondebio), Vijay Pande (@vijaypande), and Sonal Chokshi (@smc90)</p><p>On average, only 1 out of 20 medicines works when we actually bring them into the human body, and these rates of success haven't moved much in the ph ... Show More